HNF4A and cancer: Aberrant Wnt/β‐catenin activation has been identified as a driver event in a number of cancer types; accumulation of cytoplasmic β‐catenin and subsequent entry into the nucleus leads to activation of the TCF/LEF transcriptional program, promoting cell survival (Daneman et al., 2009).